← FDA Drug Approvals (Drugs@FDA)
RESERPINE, HYDROCHLOROTHIAZIDE, AND HYDRALAZINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LEDERLE · Approved 1983-09-07
Drug application
- FDA Application #
ANDA087709- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RESERPINE, HYDROCHLOROTHIAZIDE, AND HYDRALAZINE HYDROCHLORIDE
- Generic name
- Hydralazine Hydrochloride
- Active ingredients
- HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- LEDERLE
- First approval
- 1983-09-07
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown